Jeff Atkinson, NP
Family · Lindon, UTNPI 1295231850
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.3%), travel and lodging and other — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Medtronic at 38.9% of the total. 2025 is the largest year on record at $3,416, more than ten times the $18 reported in 2021. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $37.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$1K
- Relievant Medsystems, Inc.$808
- AbbVie$564
- Baxter Healthcare$416
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$285
- plus $2K from 25 others
What the payments were for
- Travel & lodging$2,85437%
- Food & beverage$4,33956%
- Education$991%
- Other$4165%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 52 | $2,998 |
| Boston Scientific | 19 | $1,042 |
| Relievant Medsystems, Inc. | 1 | $808 |
| AbbVie | 30 | $564 |
| Baxter Healthcare | 1 | $416 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $285 |
| Collegium Pharmaceutical, Inc. | 18 | $278 |
| Braeburn Inc. | 8 | $208 |
| Nevro Corp. | 4 | $120 |
| Indivior Inc. | 5 | $104 |
| Novo Nordisk | 6 | $97 |
| Exeltis, USA Inc. | 2 | $97 |
| Lilly USA, LLC | 4 | $73 |
| Supernus Pharmaceuticals, Inc. | 3 | $71 |
| AstraZeneca | 4 | $68 |
| Organon | 3 | $62 |
| Amgen(2 entities) | 3 | $52 |
| Idorsia Pharmaceuticals US Inc | 3 | $44 |
| Johnson & Johnson | 2 | $44 |
| Saluda Medical Americas, Inc. | 3 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Bayer | 2 | $28 |
| Pfizer | 2 | $28 |
| Edwards Lifesciences | 2 | $27 |
| Avanos Medical | 1 | $27 |
| SPR Therapeutics, Inc | 1 | $26 |
| Cranial Technologies, Inc | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $18 |
| GSK | 1 | $18 |
| Stryker | 1 | $14 |
| Painteq LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,620
- VenaSeal$1,099
- INTELLIS ADAPTIVESTIM$721
- BRIXADI$115
How this compares
$7,708 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 28 | $3,059 |
| Pregabalin | 161 | $3,016 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 88 | $2,244 |
| Celecoxib | 118 | $2,212 |
| Armodafinil | 13 | $1,301 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 46 | $1,239 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $1,207 |
| Buprenorphine Hcl | 15 | $1,052 |
| Ondansetron OdtOndansetron | 23 | $993 |
| Gabapentin | 39 | $873 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 29 | $855 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $616 |
| Zolpidem Tartrate | 33 | $587 |
| Oxycodone Hcl | 39 | $545 |
| Cyclobenzaprine Hcl | 35 | $497 |
Paid to pharmacies, not to this prescriber.
Other family in Lindon
- Stephanie GodfreyLindon$358K
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$395K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Mary SteinbackSalt Lake City$189K
- Shannon FordSouth Jordan$186K
- Jennalyn MayeuxSalt Lake City$151K
- Brett RawlinsKaysville$149K
- Shelby MillerSandy$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.